FMWA
ALXN
Forvis Mazars Wealth Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-12,329
| Closed | -$2.27M | – | 282 |
|
|
2021
Q2 | $2.27M | Sell |
12,329
-2,464
| -17% | -$453K | 0.11% | 86 |
|
|
2021
Q1 | $2.26M | Sell |
14,793
-694
| -4% | -$106K | 0.11% | 85 |
|
|
2020
Q4 | $2.42M | Buy |
15,487
+348
| +2% | +$54.4K | 0.12% | 91 |
|
|
2020
Q3 | $1.73M | Buy |
15,139
+1,353
| +10% | +$155K | 0.1% | 99 |
|
|
2020
Q2 | $1.55M | Buy |
13,786
+3,336
| +32% | +$374K | 0.1% | 102 |
|
|
2020
Q1 | $938K | Buy |
10,450
+6,014
| +136% | +$540K | 0.08% | 113 |
|
|
2019
Q4 | $480K | Buy |
+4,436
| New | +$480K | 0.03% | 197 |
|